Paper41018564
Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions.
Fitch A and 2 others. Obes Pillars, 2025. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions. Papers, record 41018564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41018564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References124
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35971075 | Primary care physicians' knowledge and attitudes about obesity, adherence to treatment guidelines and association with confidence to treat obesity: a Swedish survey study. | BMC Prim Care | 2022 | https://conductscience.org/library/papers/35971075 | PubMed |
| 2 | 21975647 | Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake. | Am J Physiol Regul Integr Comp Physiol | 2011 | https://conductscience.org/library/papers/21975647 | PubMed |
| 3 | 37689140 | The effectiveness of medical nutrition therapy provided by a dietitian in adults with prediabetes: a systematic review and meta-analysis. | Am J Clin Nutr | 2023 | https://conductscience.org/library/papers/37689140 | PubMed |
| 4 | 34775881 | Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. | Postgrad Med | 2022 | https://conductscience.org/library/papers/34775881 | PubMed |
| 5 | 37990727 | Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. | Obes Pillars | 2022 | https://conductscience.org/library/papers/37990727 | PubMed |
| 6 | 38544798 | Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38544798 | PubMed |
| 7 | 35227529 | Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. | Clin Nutr | 2022 | https://conductscience.org/library/papers/35227529 | PubMed |
| 8 | 38085928 | Nutrition and physical activity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022. | Obes Pillars | 2022 | https://conductscience.org/library/papers/38085928 | PubMed |
| 9 | 37990728 | Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. | Obes Pillars | 2022 | https://conductscience.org/library/papers/37990728 | PubMed |
| 10 | 32753461 | Obesity in adults: a clinical practice guideline. | CMAJ | 2020 | https://conductscience.org/library/papers/32753461 | PubMed |
| 11 | 39726721 | Why are we still in need for novel anti-obesity medications? | Lancet Reg Health Eur | 2024 | https://conductscience.org/library/papers/39726721 | PubMed |
| 12 | 39386160 | Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/39386160 | PubMed |
| 13 | 39710882 | GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials. | Obesity (Silver Spring) | 2025 | https://conductscience.org/library/papers/39710882 | PubMed |
| 14 | 36458843 | How might enhanced interprofessional collaboration between primary care physicians and registered dietitian nutritionists impact clinical outcomes related to obesity and associated illnesses? A commentary. | Public Health Nutr | 2023 | https://conductscience.org/library/papers/36458843 | PubMed |
| 15 | 33899338 | Weight Can't Wait: A Guide to Discussing Obesity and Organizing Treatment in the Primary Care Setting. | Obesity (Silver Spring) | 2021 | https://conductscience.org/library/papers/33899338 | PubMed |
| 16 | 37518832 | Moving beyond eat less, move more using willpower: Reframing obesity as a chronic disease impact of the 2020 Canadian obesity guidelines reframed narrative on perceptions of self and the patient-provider relationship. | Clin Obes | 2023 | https://conductscience.org/library/papers/37518832 | PubMed |
| 17 | 23225173 | How do we improve patient compliance and adherence to long-term statin therapy? | Curr Atheroscler Rep | 2013 | https://conductscience.org/library/papers/23225173 | PubMed |
| 18 | 39109480 | The latest evidence and clinical guidelines for use of meal replacements in very-low-calorie diets or low-calorie diets for the treatment of obesity. | Diabetes Obes Metab | 2024 | https://conductscience.org/library/papers/39109480 | PubMed |
| 19 | 37661106 | The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. | Am J Clin Nutr | 2023 | https://conductscience.org/library/papers/37661106 | PubMed |
| 20 | 39582489 | Recent achievements and future directions of anti-obesity medications. | Lancet Reg Health Eur | 2024 | https://conductscience.org/library/papers/39582489 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42796978 | Foods as Modulators of GLP-1 Secretion. | Nutrients | 2026 | https://conductscience.org/library/papers/42796978 | PubMed |
| 42738931 | Hidden Malnutrition in the GLP-1 Era: Micronutrient Status, Protein Adequacy, and Lean Mass as Emerging Nutritional Considerations-A Narrative Review. | Nutrients | 2026 | https://conductscience.org/library/papers/42738931 | PubMed |
| 42738922 | Lifestyle Medicine as Co-Therapy During Incretin-Based Anti-Obesity Pharmacotherapy: Integrating Physical Activity, Nutrition, and Behavioral Strategies for Long-Term Success. | Nutrients | 2026 | https://conductscience.org/library/papers/42738922 | PubMed |
| 42701351 | The Evolution of Medications for Obesity Management. | JGH Open | 2026 | https://conductscience.org/library/papers/42701351 | PubMed |
| 42654223 | Do Patients Receiving GLP-1 Receptor Agonists for Weight Loss Require Structured Dietetic Care? Lessons from Metabolic and Bariatric Surgery (MBS) Pathways. | Nutrients | 2026 | https://conductscience.org/library/papers/42654223 | PubMed |
| 42589975 | Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy. | J Clin Med | 2026 | https://conductscience.org/library/papers/42589975 | PubMed |
| 42529748 | Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation. | Obes Pillars | 2026 | https://conductscience.org/library/papers/42529748 | PubMed |
| 42382663 | Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework. | Obes Pillars | 2026 | https://conductscience.org/library/papers/42382663 | PubMed |
| 42323133 | Avoiding Malnutrition in the Era of Glucagon-Like Peptide-1 Medications: Emerging Evidence and Opportunities for Integrated Nutrition Care. | J Nutr | 2026 | https://conductscience.org/library/papers/42323133 | PubMed |
| 42280393 | Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance. | Nutrients | 2026 | https://conductscience.org/library/papers/42280393 | PubMed |
| 42210374 | Shrinking appetites: Will GLP-1 adoption in high-income countries accelerate Big Food's push into low- and middle-income countries? | Global Health | 2026 | https://conductscience.org/library/papers/42210374 | PubMed |
| 41815964 | Nutrition literacy and socio-demographic determinants among Chinese women of childbearing age. | Front Public Health | 2026 | https://conductscience.org/library/papers/41815964 | PubMed |
| 41515247 | Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review. | Nutrients | 2025 | https://conductscience.org/library/papers/41515247 | PubMed |
| 41502845 | Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach. | Obes Pillars | 2026 | https://conductscience.org/library/papers/41502845 | PubMed |
| 41373949 | Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery? | Nutrients | 2025 | https://conductscience.org/library/papers/41373949 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41018564
GET https://conductscience.org/api/papers/v1/41018564/references?page=2